Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
3(37.5%)
N/A
2(25.0%)
Phase 1
2(25.0%)
Phase 2
1(12.5%)
8Total
Phase 4(3)
N/A(2)
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)